恩诺沙星对猪源沙门氏菌的药敏折点
Susceptibility breakpoint for enrofloxacin against swine Salmonella spp.
机构信息
National Reference Laboratory of Veterinary Drug Residues/MOA Key Laboratory of the Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei, People's Republic of China.
出版信息
J Clin Microbiol. 2013 Sep;51(9):3070-2. doi: 10.1128/JCM.01096-13. Epub 2013 Jun 19.
Abstract
Susceptibility breakpoints are crucial for prudent use of antimicrobials. This study has developed the first susceptibility breakpoint (MIC ≤ 0.25 μg/ml) for enrofloxacin against swine Salmonella spp. based on wild-type cutoff (COWT) and pharmacokinetic-pharmacodynamic (PK-PD) cutoff (COPD) values, consequently providing a criterion for susceptibility testing and clinical usage of enrofloxacin.
摘要
药敏折点对于谨慎使用抗菌药物至关重要。本研究基于野生型折点（COWT）和药代动力学-药效学（PK-PD）折点（COPD）值，制定了恩诺沙星对猪源沙门氏菌的第一个药敏折点（MIC≤0.25μg/ml），为恩诺沙星的药敏检测和临床应用提供了依据。
相似文献
1
Susceptibility breakpoint for enrofloxacin against swine Salmonella spp.恩诺沙星对猪源沙门氏菌的药敏折点
J Clin Microbiol. 2013 Sep;51(9):3070-2. doi: 10.1128/JCM.01096-13. Epub 2013 Jun 19.
2
The effects of oral and intramuscular administration and dose escalation of enrofloxacin on the selection of quinolone resistance among Salmonella and coliforms in pigs.恩诺沙星口服和肌肉注射以及剂量递增对猪沙门氏菌和大肠菌群中喹诺酮耐药性选择的影响。
Res Vet Sci. 2003 Dec;75(3):185-93. doi: 10.1016/s0034-5288(03)00112-7.
3
Susceptibility breakpoint for Danofloxacin against swine Escherichia coli.达氟沙星对猪源大肠杆菌的药敏断点
BMC Vet Res. 2019 Feb 4;15(1):51. doi: 10.1186/s12917-019-1783-2.
4
Prevalence and antimicrobial susceptibility of Salmonella infections in free-range pigs.散养猪中沙门氏菌感染的流行情况和药敏性。
Vet J. 2011 Oct;190(1):176-8. doi: 10.1016/j.tvjl.2010.09.009. Epub 2010 Oct 6.
5
Epidemiologic relationship between fluoroquinolone-resistant Salmonella enterica Serovar Choleraesuis strains isolated from humans and pigs in Taiwan (1997 to 2002).1997年至2002年台湾地区从人和猪身上分离出的耐氟喹诺酮类肠炎沙门氏菌猪霍乱血清型菌株之间的流行病学关系。
J Clin Microbiol. 2005 Jun;43(6):2798-804. doi: 10.1128/JCM.43.6.2798-2804.2005.
6
Distribution of Salmonella Serovars and Antimicrobial Susceptibility from Poultry and Swine Farms in Central Vietnam.越南中部家禽和养猪场中沙门氏菌血清型分布及抗菌药敏性
Zoonoses Public Health. 2016 Nov;63(7):569-576. doi: 10.1111/zph.12265. Epub 2016 Mar 8.
7
Appearance of blaCMY-2)gene-positive Salmonella isolates of pig origin in China.中国猪源产blaCMY-2基因沙门氏菌分离株的出现情况。
Int J Antimicrob Agents. 2008 Mar;31(3):292-3. doi: 10.1016/j.ijantimicag.2007.10.023. Epub 2008 Jan 4.
8
Intracellular concentrations of enrofloxacin in quinolone-resistant Salmonella enterica subspecies enterica serovar Choleraesuis.肠沙门氏菌亚种肠炎血清型耐恩诺沙星株细胞内恩诺沙星浓度。
Int J Antimicrob Agents. 2009 Dec;34(6):592-5. doi: 10.1016/j.ijantimicag.2009.07.009. Epub 2009 Sep 4.
9
Salmonella species in piglets and weaners from Uganda: prevalence, antimicrobial resistance and herd-level risk factors.乌干达仔猪和断奶仔猪中沙门氏菌的流行情况、抗菌药物耐药性和群体水平的风险因素。
Prev Vet Med. 2014 Jul 1;115(1-2):39-47. doi: 10.1016/j.prevetmed.2014.03.009. Epub 2014 Mar 18.
10
Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Escherichia coli, and Salmonella choleraesuis recovered from Taiwanese swine.从台湾猪只分离出的胸膜肺炎放线杆菌、大肠杆菌和猪霍乱沙门氏菌的药敏性
J Vet Diagn Invest. 2002 Mar;14(2):153-7. doi: 10.1177/104063870201400210.
引用本文的文献
1
Development of a novel chimeric lysin to combine parental phage lysin and cefquinome for preventing sow endometritis after artificial insemination.开发一种新型嵌合溶素，将亲本噬菌体溶素和头孢喹肟结合起来，用于预防人工授精后母猪子宫内膜炎。
Vet Res. 2025 Feb 11;56(1):39. doi: 10.1186/s13567-025-01457-4.
2
Genetic characterization of ESBL-producing and ciprofloxacin-resistant from Belgian broilers and pigs.比利时肉鸡和猪中产超广谱β-内酰胺酶（ESBL）及耐环丙沙星菌株的基因特征分析
Front Microbiol. 2023 Apr 6;14:1150470. doi: 10.3389/fmicb.2023.1150470. eCollection 2023.
3
Optimal Regimens and Clinical Breakpoint of Avilamycin Against in Swine Based on PK-PD Study.基于药代动力学-药效学研究的阿维拉霉素对猪的最佳给药方案及临床断点
Front Pharmacol. 2022 Feb 24;13:769539. doi: 10.3389/fphar.2022.769539. eCollection 2022.
4
Application of a Physiologically Based Pharmacokinetic Model to Develop a Veterinary Amorphous Enrofloxacin Solid Dispersion.基于生理药代动力学模型开发兽用无定形恩诺沙星固体分散体的应用。
Pharmaceutics. 2021 Apr 22;13(5):602. doi: 10.3390/pharmaceutics13050602.
5
Antibiotic Resistance Profiles of Recovered From Finishing Pigs and Slaughter Facilities in Henan, China.从中国河南的育肥猪和屠宰场分离出的细菌的抗生素耐药性概况 。
你提供的原文似乎不完整，“Recovered From”前面应该还有具体的细菌等相关内容。
Front Microbiol. 2019 Jul 4;10:1513. doi: 10.3389/fmicb.2019.01513. eCollection 2019.
6
Susceptibility breakpoint for Danofloxacin against swine Escherichia coli.达氟沙星对猪源大肠杆菌的药敏断点
BMC Vet Res. 2019 Feb 4;15(1):51. doi: 10.1186/s12917-019-1783-2.
本文引用的文献
1
Rifampin breakpoint for Acinetobacter baumannii based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation.基于蒙特卡洛模拟的药代动力学-药效学模型确定的鲍曼不动杆菌利福平折点
Rev Esp Quimioter. 2012 Jun;25(2):134-8.
2
Simultaneous determination of fluoroquinolones in foods of animal origin by a high performance liquid chromatography and a liquid chromatography tandem mass spectrometry with accelerated solvent extraction.高效液相色谱-串联质谱法同时测定动物源性食品中的氟喹诺酮类药物
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Feb 15;885-886:150-9. doi: 10.1016/j.jchromb.2011.12.016. Epub 2011 Dec 23.
3
Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs.在给猪注射恩诺沙星后，采用体内超滤采样技术对恩诺沙星及其活性代谢物进行分布研究。
J Vet Pharmacol Ther. 2012 Oct;35(5):452-9. doi: 10.1111/j.1365-2885.2011.01338.x. Epub 2011 Sep 14.
4
Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs.恩诺沙星在健康猪肌肉注射后在鼻分泌物中的渗透情况以及鼻分泌物与血浆中恩诺沙星浓度之间的关系。
J Vet Pharmacol Ther. 2010 Apr;33(2):183-8. doi: 10.1111/j.1365-2885.2009.01123.x.
5
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.根据临床和实验室标准协会的肉汤微量稀释方法，确定了烟曲霉野生型 MIC 分布和三种三唑类药物的流行病学截断值。
J Clin Microbiol. 2009 Oct;47(10):3142-6. doi: 10.1128/JCM.00940-09. Epub 2009 Aug 19.
6
Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation.基于药代动力学-药效学模型及蒙特卡洛模拟的革兰氏阴性需氧菌抗菌药物断点值
J Antimicrob Chemother. 2008 Mar;61(3):621-8. doi: 10.1093/jac/dkm536. Epub 2008 Feb 4.
7
Setting and revising antibacterial susceptibility breakpoints.设定和修订抗菌药物敏感性断点
Clin Microbiol Rev. 2007 Jul;20(3):391-408, table of contents. doi: 10.1128/CMR.00047-06.
8
Reevaluation of current susceptibility breakpoints for Gram-negative rods based on pharmacodynamic assessment.基于药效学评估对革兰氏阴性杆菌当前药敏断点的重新评估。
Diagn Microbiol Infect Dis. 2007 Jul;58(3):337-44. doi: 10.1016/j.diagmicrobio.2007.01.004. Epub 2007 Mar 9.
9
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values.细菌野生型最低抑菌浓度（MIC）值分布的统计学特征及流行病学临界值的确定。
Clin Microbiol Infect. 2006 May;12(5):418-25. doi: 10.1111/j.1469-0691.2006.01377.x.
10
Application of fluoroquinolone pharmacodynamics.氟喹诺酮类药物动力学的应用。
J Antimicrob Chemother. 2000 Nov;46(5):669-83. doi: 10.1093/jac/46.5.669.
Zotero 插件